• KOL
    • Prostate Cancer
    • Akihiro Kawauchi
    • Akihiro Kawauchi: Influence Statistics

      Akihiro Kawauchi

      Akihiro Kawauchi

      Shiga University of Medical Science: Shiga Ika Daigaku | Department of Urology, Shiga University of Medical Science, Shiga, Japan. | Department of Urology, Shiga University of ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Akihiro Kawauchi:Expert Impact

      Concepts for whichAkihiro Kawauchihas direct influence:Prostate cancer,Germ cell,Bladder capacity,Bladder cancer,Nocturnal enuresis,Renal cell carcinoma,Cyclin d1b,Penile erection.

      Akihiro Kawauchi:KOL impact

      Concepts related to the work of other authors for whichfor which Akihiro Kawauchi has influence:Nocturnal enuresis,Prostate cancer,Erectile dysfunction,Renal cell carcinoma,Apoptosis protein,Urinary tract,Overactive bladder.

      KOL Resume for Akihiro Kawauchi

      Year
      2022

      Shiga University of Medical Science: Shiga Ika Daigaku

      2021

      Department of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan

      2020

      Department of Urology, Shiga University of Medical Science, Otsu, Japan

      2019

      Department of Urology, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan.

      2018

      Department of Urology, Shiga University of Medical Science, Seta Tsukinowa-cho, 520-2192, Otsu, Shiga, Japan

      2017

      Division of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan

      2016

      Department of Urology, Shiga University of Medical Science Hospital, Seta Tsukinowa-cho, Otsu City, Shiga, Japan

      2015

      Depatrment of Urology, Shiga University of Medical Science, Otsu, Japan, .

      Shiga University of Medical Science Department of Urology

      2014

      Department of Urology, Shiga University of Medical Science, Otsu, Japan, .

      2013

      Kyoto Prefectural University of Medicine Department of Urology Graduate School of Medical Science Kyoto Japan

      2012

      Department of Urology, Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan

      2011

      Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto

      2010

      Department of Molecular Cell Physiology, Department of Urology, Department of Respiratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, These authors equally contributed to the present work

      Kyoto, Japan

      2009

      Department of Urology, Kyoto Prefectural University of Medicine, Uji, Kyoto, Japan

      2008

      Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, 602-8566, Kyoto, Japan

      2007

      Department of Urology, Kyoto Prefectural University, Kyoto 602-8319, Japan

      2006

      Department of Urology, Kyoto Prefectural University of Medicine and

      Kyoto Prefectural University of Medicine, Kyoto, Japan; Osaka University, Osaka, Japan

      2005

      Departments of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 
*Omihachiman City Hospital, Shiga, Japan, 
†Nantan General Hospital, Kyoto, Japan, and 
¶Nagoya Urology Hospital, Nagoya, Japan

      2004

      Sweden New Zealand Australia/Hong Kong Italy Italy Germany S. Korea USA Japan Sweden France New Zealand Denmark USA Belgium Hong Kong on Behalf of the International Children’s Continence Society (ICCS)

      From the Section of Laparoscopic and Minimally Invasive Surgery, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio and the Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

      Department of Microbiology, Immunology, and Molecular Genetics, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California at Los Angeles, Los Angeles, CA

      2003

      Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kyoto, Japan

      2002

      Departments of Urology, Kyoto Prefectural University of Medicine, Kyoto, and

      2001

      Department of Urology, Kyoto Prefectural University of Medicine, Kamigyo‐ku, Kyoto 602‐8566, Japan

      2000

      From the Department of Urology, Kyoto Prefectural University of Medicine, Kyoto and Department of Physiology, Fukushima Medical University School of Medicine, Fukushima, Japan

      Department of Urology,Research Institute for Neurological Diseases and Geriatrics,Kyoto Prefectural University of Medicine,Kawaramachi Hirokoji,Kamigyo-ku,Kyoto 602-8566

      1998

      Department of Urology, Kyoto Prefectural University of Medicine, Japan

      1996

      Department of Urology, Kyoto Prefectural University of Medicine, Japan.

      1993

      Department of Urology, Kyoto Prefectural University of Medicine.

      Sample of concepts for which Akihiro Kawauchi is among the top experts in the world.
      Concept World rank
      242346 #1
      phb2 proteins #1
      monosymptomatic enuretic #1
      icg cord surgery #1
      24 c7orf24 #1
      life enuretic children #1
      “ nocturnal #1
      nocturia nonenuretic #1
      nonenuretic #1
      n‑cadherin expression #1
      inhibitor upregulation #1
      γ ggct #1
      349 seconds #1
      testicular veins arteries #1
      effectiveness alarm #1
      gammaglutamylcyclotransferase ggct #1
      invasiveness 3d‑spheroid formation #1
      pharmacotherapy responders #1
      mtor inhibitor phosphorylation #1
      ggct highly #1
      frequency enuresis #1
      ggct cancer cells #1
      cdk inhibitor upregulation #1
      ggct knockdown #1
      reflux nocturnal enuresis #1
      ggct proteins #1
      sds evaluation treatment #1
      nocturnal enuresis incidence #1
      electrovaporization renal #1
      therapy alarm #1
      function enuresis #1
      electrovaporization spherical electrode #1
      phb2 ggct #1
      enuresis incidence #1
      enuretic bladder capacity #1
      pdk4 inhibitor cryptotanshinone #1
      gammaglutamylcyclotransferase #1
      suppressed invasiveness #1
      spermatic artery lymphatics #1
      inhibition ggct #1
      response enuresis #1
      japanese nonenuretic children #1
      pharmacotherapy prognosis #1
      endosalpingiosis urinary bladder #1
      kidkindl protocol #1
      small nuv #1
      inhibition gamma glutamylcyclotransferase #1
      life kidkindl protocol #1
      nocturnal enuresis guidelines #1
      pharmacotherapy effective rate #1

      Prominent publications by Akihiro Kawauchi

      KOL-Index: 14014

      OBJECTIVES: To examine the clinical utility of the prostate cancer gene 3 (PCA3) urine test in predicting prostate cancer in Japanese men undergoing prostate biopsy.

      METHOD: The study group included 105 men who underwent extended prostate biopsy based on an elevated serum prostate-specific antigen (PSA). In all cases, the patients' race was Asian. Urine specimens were collected after digital rectal examination, and PCA3 score (PCA3/PSA mRNA) was determined in the urine using the APTIMA ...

      Known for Prostate Cancer | Pca3 Score | Psa Density | Urine Assay | Gene 3
      KOL-Index: 13889

      Dihydropyrimidine dehydrogenase (DPD) is the rate-limiting enzyme in the pathway of uracil and thymine catabolism. DPD is also the principal enzyme involved in the degradation of 5-fluorouracil (5-FU), which is one of the anticancer chemotherapeutic agents currently used in the treatment of bladder cancer. Little is known about the significance of DPD activity in human cancers. We investigated the activity of DPD in 74 bladder cancers and the relationship between the DPD activity and the ...

      Known for Dihydropyrimidine Dehydrogenase | Dpd Activity | Bladder Cancer | Tumor Carcinoma | Antineoplastic Biomarkers
      KOL-Index: 13484

      PURPOSE: Second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) was recently identified as a protein that is released from mitochondria in response to apoptotic stimuli and promotes apoptosis by antagonizing inhibitor of apoptosis proteins. Furthermore, Smac/DIABLO plays an important regulatory role in the sensitization of cancer cells to both immune- and drug-induced apoptosis. However, little is known about the clinical ...

      Known for Smac Diablo | Renal Cell Carcinoma | Prognostic Significance | Apoptosis Proteins | Neoplastic Humans
      KOL-Index: 11614

      PURPOSE: We assessed patient quality of life specific to each of the 7 items on the International Prostate Symptom Score, as evaluated with a novel visual analog scale questionnaire.

      MATERIALS AND METHODS: A total of 246 male patients with a chief complaint of lower urinary tract symptom were asked to complete the International Prostate Symptom Score and visual analog scale questionnaires to assess bother or satisfaction regarding patient quality of life specific to each of the 7 items ...

      Known for Symptom Score | International Prostate | Visual Analog | Quality Life | Patient Specific
      KOL-Index: 10523

      BACKGROUND: We retrospectively reviewed a large series of Japanese men with histologically proven prostate cancer to assess the clinical characteristics of the cancer in three different eras of prostate cancer management since prostate-specific antigen (PSA) testing started in 1988.

      METHODS: The medical records of 1125 patients treated between 1975 and 2002 were reviewed with respect to age, chief complaints, clinical stage, tumor grade, treatment options at each stage, and prognosis. We ...

      Known for Prostate Cancer | Psa Phase | Specific Antigen | Clinical Characteristics | Age Patients
      KOL-Index: 9778

      BACKGROUND: The aim of this study is to ascertain whether Bayer complexed PSA (cPSA) and volume referenced cPSA could enhance the detection of prostate cancer in Japanese men.

      METHODS: A total of 214 Japanese men whose serum total PSA (tPSA) values ranged from 1.2 ng/ml to 4600 ng/ml were enrolled from two institutions. Serum samples for tPSA, free PSA, PSA-alpha-1-antichymotripsin (PSA-ACT) and cPSA (ADVIA-Centaur) were obtained in all cases. In addition, total gland (TGV) as well as ...

      Known for Prostate Cancer | Tpsa Cpsa | Specific Antigen | Psa Ratio | Prostatic Neoplasms
      KOL-Index: 9648

      PURPOSE: We report our initial experience with hand assisted retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma and compared our results to those of a contemporary series of open nephroureterectomy.

      MATERIALS AND METHODS: Clinical data on 34 consecutive patients who underwent hand assisted retroperitoneoscopic nephroureterectomy were reviewed and compared with those on 34 who underwent open nephroureterectomy. All specimens were extracted ...

      Known for Hand Assisted | Laparoscopy Surgery | Transitional Cell | Bladder Recurrence | Initial Experience
      KOL-Index: 9609

      AIM: Bladder diaries including bladder perception grades were analyzed to assess overactive bladder (OAB) symptoms in community-dwelling women 40 years of age or older.

      METHODS: Three hundred ten women (mean 58 years) completed a 3-day bladder diary. The perception grades were defined as follows: 0 = no bladder sensation, 1 = sensation of bladder filling without desire to void, 2 = desire to void, 3 = strong desire to void, 4 = urgency without urge urinary incontinence (UUI), and 5 = ...

      Known for Bladder Diary | Urinary Perception | Voided Volume | Normal Urgency | Uui Oabwet
      KOL-Index: 9555

      BACKGROUND: For men with clinically localized prostate cancer and candidates to receive radical prostatectomy (RP) a main concern is a cancer recurrence after treatment. Although previous studies have demonstrated the diagnostic utility of diffusion-weighted imaging (DWI) for prostate cancer, the prognostic value of pretreatment DWI has not been investigated yet.

      PURPOSE: To investigate the incremental value of MRI-based T staging using DWI and T2-weighted imaging (T2WI) as compared with ...

      Known for Prostate Cancer | Biochemical Recurrence | T2wi Dwi | Weighted Mri | Resonance Imaging
      KOL-Index: 9353

      PURPOSE: We describe the technical aspects of real-time transrectal ultrasound (TRUS) monitoring and guidance during laparoscopic radical prostatectomy (LRP). Furthermore, we describe the TRUS visualized anatomy of periprostatic structures during LRP.

      MATERIALS AND METHODS: In 25 consecutive patients undergoing transperitoneal LRP, baseline preoperative, real-time intraoperative and immediate postoperative TRUS evaluations were performed. To define periprostatic anatomy precisely TRUS ...

      Known for Lrp Trus | Computerassisted Ultrasonography | Laparoscopic Radical | Time Transrectal | Periprostatic Anatomy
      KOL-Index: 9227

      The aim of this study is to evaluate the diagnostic performance of transrectal real-time elastography (TRTE) to differentiate benign from malignant prostatic lesions, with pathologic diagnosis obtained by prostatic needle biopsy. Conventional gray scale transrectal ultrasonography (TRUS) and power Doppler ultrasonography (PDUS) were performed in 107 men who had elevated serum prostate-specific antigen level >4 ng/mL or abnormal findings on digital rectal examination. For baseline TRUS ...

      Known for Systematic Biopsy | Doppler Ultrasonography | Detection Rate | Time Elastography | Transrectal Real
      KOL-Index: 9029

      In order to evaluate the erectile function in male renal failure patients treated with hemodialysis (HD), we investigated the International Index of Erectile Function (IIEF) in patients and healthy controls. The subjects were 174 male patients treated with HD, of whom 43 had diabetes mellitus (DM) and the remaining 131 patients did not have DM. The controls were 1133 healthy males. We evaluated the prevalence of erectile dysfunction (ED) using the erectile function (EF) score, which is ...

      Known for Erectile Function | Renal Failure | Hd Patients | Age Severity | Higher Controls

      Key People For Prostate Cancer

      Top KOLs in the world
      #1
      Ahmedin M Jemal
      united states breast cancer addis ababa
      #2
      Peter T Scardino
      prostate cancer active surveillance erectile function
      #3
      Rebecca L Siegel
      united states colorectal cancer incidence rates
      #4
      Johnathan I Jonathan
      prostate cancer gleason score needle biopsy
      #5
      Philip W Kantoff
      prostate cancer psma adc androgen deprivation therapy
      #6
      PATRICK CRAIG Walsh
      prostate cancer specific antigen pathological stage

      Shiga University of Medical Science: Shiga Ika Daigaku | Department of Urology, Shiga University of Medical Science, Shiga, Japan. | Department of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan | Departme

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.